Trademark: 85752604
Status Date
Monday, June 20, 2016
Filing Date
Friday, October 12, 2012
Published for Opposition
Tuesday, March 19, 2013
Abandoned Date
Monday, June 20, 2016
5 Human pharmaceuticals for the prevention or treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases and respiratory diseases
Jun 20, 2016
Abandonment Notice Mailed - No Use Statement Filed
Jun 20, 2016
Abandonment - No Use Statement Filed
Oct 27, 2015
Notice Of Approval Of Extension Request E-Mailed
Oct 26, 2015
Extension 5 Granted
Oct 21, 2015
Extension 5 Filed
Oct 21, 2015
Teas Extension Received
Apr 17, 2015
Notice Of Approval Of Extension Request E-Mailed
Apr 16, 2015
Extension 4 Granted
Apr 9, 2015
Extension 4 Filed
Apr 9, 2015
Teas Extension Received
Oct 16, 2014
Notice Of Approval Of Extension Request E-Mailed
Oct 15, 2014
Extension 3 Granted
Oct 13, 2014
Extension 3 Filed
Oct 13, 2014
Teas Extension Received
Apr 30, 2014
Notice Of Approval Of Extension Request E-Mailed
Apr 29, 2014
Extension 2 Granted
Apr 22, 2014
Extension 2 Filed
Apr 22, 2014
Teas Extension Received
Dec 10, 2013
Notice Of Approval Of Extension Request E-Mailed
Dec 9, 2013
Extension 1 Granted
Oct 21, 2013
Extension 1 Filed
Dec 7, 2013
Case Assigned To Intent To Use Paralegal
Oct 21, 2013
Teas Extension Received
May 14, 2013
Noa E-Mailed - Sou Required From Applicant
Mar 19, 2013
Official Gazette Publication Confirmation E-Mailed
Mar 19, 2013
Published For Opposition
Feb 27, 2013
Notification Of Notice Of Publication E-Mailed
Feb 7, 2013
Approved For Pub - Principal Register
Feb 6, 2013
Assigned To Examiner
Oct 18, 2012
Notice Of Pseudo Mark Mailed
Oct 17, 2012
New Application Office Supplied Data Entered In Tram
Oct 16, 2012
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
